The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
Open accessAbstract
Diagnosis, treatment, response monitoring, and outcome of pediatric acute myeloid leukemia (AML) have made enormous progress during the past decades. Because AML is a rare type of childhood cancer, with an incidence of approximately seven occurrences per 1 million children annually, national and international collaborative efforts have evolved. This overview describes these efforts and includes a summary of the history and contributions of each of the main collaborative pediatric AML groups worldwide. The focus is on translational and clinical research, which includes past, current, and future clinical trials. Separate sections concern acute promyelocytic leukemia, myeloid leukemia of Down syndrome, and relapsed AML. A plethora of novel antileukemic agents that have emerged, including new classes of drugs, are summarized as well. Finally, an important aspect of the treatment of pediatric AML—supportive care—and late effects are discussed. The future is bright, with a wide range of emerging innovative therapies and with more and more international collaboration that ultimately aim to cure all children with AML, with fewer adverse effects and without late effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Hematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300874 · Cited by 1,611
Carfilzomib, Lenalidomide, and Dexamethasone for Relapsed Multiple Myeloma
Stewart, A. K., Rajkumar, S. V., Dimopoulos, M. A., Masszi, T., Špička, I., Oriol, A., Hájek, R., Rosiñol, L., Siegel, D. S., Mihaylov, G. G., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1411321 · Cited by 1,332 · cited 1×
“The second-generation proteasome inhibitor carfilzomib, approved by the FDA for multiple myeloma, is now under evaluation in pediatric leukemia (NCT02303821).(128)”
BackgroundComplete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
Soignet, S. L., Maslak, P., Wang, Z.-G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391901 · Cited by 1,213
Castaigne, S., Pautas, C., Terré, C., Raffoux, E., Bordessoule, D., Bastie, J.-N., Legrand, O., Thomas, X., Turlure, P., Reman, O., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60485-1 · Cited by 1,015
Selective Killing of Mixed Lineage Leukemia Cells by a Potent Small-Molecule DOT1L Inhibitor
Daigle, S. R., Olhava, E. J., Therkelsen, C. A., Majer, C. R., Sneeringer, C. J., Song, J., Johnston, L. D., Scott, M. P., Smith, J. J., Xiao, Y., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.009 · Cited by 923
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Pui, C.-H., Carroll, W. L., Meshinchi, S., & Arceci, R. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7405 · Cited by 842
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
Löwenberg, B., Ossenkoppele, G. J., van Putten, W., Schouten, H. C., Graux, C., Ferrant, A., Sonneveld, P., Maertens, J., Jongen-Lavrencic, M., von Lilienfeld-Toal, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0901409 · Cited by 828
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Smith, C. C., Wang, Q., Chin, C.-S., Salerno, S., Damon, L. E., Levis, M. J., Perl, A. E., Travers, K. J., Wang, S., Hunt, J. P., et al. (2012) · Nature · doi:10.1038/nature11016 · Cited by 735
Burnett, A. K., Hills, R. K., Milligan, D., Kjeldsen, L., Kell, J., Russell, N. H., Yin, J. A. L., Hunter, A., Goldstone, A. H., & Wheatley, K. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.4310 · Cited by 657
Rubnitz, J. E., Inaba, H., Dahl, G., Ribeiro, R. C., Bowman, W. P., Taub, J., Pounds, S., Razzouk, B. I., Lacayo, N. J., Cao, X., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70090-5 · Cited by 584
Self-citationCreutzig, U., van den Heuvel-Eibrink, M. M., Gibson, B., Dworzak, M. N., Adachi, S., de Bont, E., Harbott, J., Hasle, H., Johnston, D., Kinoshita, A., et al. (2012) · Blood · doi:10.1182/blood-2012-03-362608 · Cited by 577
Self-citationArmenian, S. H., Hudson, M. M., Mulder, R. L., Chen, M. H., Constine, L. S., Dwyer, M., Nathan, P. C., Tissing, W. J. E., Shankar, S., Sieswerda, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70409-7 · Cited by 570
G ENETICS OF M YELOID L EUKEMIAS
Kelly, L. M., & Gilliland, D. G. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.032802.115046 · Cited by 523
The MLL recombinome of acute leukemias in 2013
Meyer, C., Hofmann, J., Burmeister, T., Gröger, D., Park, T. S., Emerenciano, M., Pombo de Oliveira, M., Renneville, A., Villarese, P., Macintyre, E., et al. (2013) · Leukemia · doi:10.1038/leu.2013.135 · Cited by 491
Self-citationGamis, A. S., Alonzo, T. A., Meshinchi, S., Sung, L., Gerbing, R. B., Raimondi, S. C., Hirsch, B. A., Kahwash, S. B., Heerema-McKenney, A., Winter, L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.55.3628 · Cited by 486
Self-citationBalgobind, B. V., Raimondi, S. C., Harbott, J., Zimmermann, M., Alonzo, T. A., Auvrignon, A., Beverloo, H. B., Chang, M., Creutzig, U., Dworzak, M. N., et al. (2009) · Blood · doi:10.1182/blood-2009-04-215152 · Cited by 445
Self-citationWeick, J., Kopecky, K., Appelbaum, F., Head, D., Kingsbury, L., Balcerzak, S., Bickers, J., Hynes, H., Welborn, J., Simon, Sr., et al. (1996) · Blood · doi:10.1182/blood.v88.8.2841.bloodjournal8882841 · Cited by 411
Burnett, A. K., Russell, N. H., Hills, R. K., Kell, J., Freeman, S., Kjeldsen, L., Hunter, A. E., Yin, J., Craddock, C. F., Dufva, I. H., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.2964 · Cited by 409
Groll, A. H., Castagnola, E., Cesaro, S., Dalle, J.-H., Engelhard, D., Hope, W., Roilides, E., Styczynski, J., Warris, A., & Lehrnbecher, T. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70017-8 · Cited by 407
Clinical implications of FLT3 mutations in pediatric AML
Meshinchi, S., Alonzo, T. A., Stirewalt, D. L., Zwaan, M., Zimmerman, M., Reinhardt, D., Kaspers, G. J. L., Heerema, N. A., Gerbing, R., Lange, B. J., et al. (2006) · Blood · doi:10.1182/blood-2006-03-009233 · Cited by 395
Self-citationCurrent management and challenges of malignant disease in the CNS in paediatric leukaemia
Pui, C.-H., & Howard, S. C. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70070-6 · Cited by 393
Lehrnbecher, T., Phillips, R., Alexander, S., Alvaro, F., Carlesse, F., Fisher, B., Hakim, H., Santolaya, M., Castagnola, E., Davis, B. L., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.42.7161 · Cited by 353
Self-citationLancet, J. E., Cortes, J. E., Hogge, D. E., Tallman, M. S., Kovacsovics, T. J., Damon, L. E., Komrokji, R., Solomon, S. R., Kolitz, J. E., Cooper, M., et al. (2014) · Blood · doi:10.1182/blood-2013-12-540971 · Cited by 339
Hollink, I. H. I. M., van den Heuvel-Eibrink, M. M., Arentsen-Peters, S. T. C. J. M., Pratcorona, M., Abbas, S., Kuipers, J. E., van Galen, J. F., Beverloo, H. B., Sonneveld, E., Kaspers, G.-J. J. L., et al. (2011) · Blood · doi:10.1182/blood-2011-04-346643 · Cited by 334
Self-citationHarrison, C. J., Hills, R. K., Moorman, A. V., Grimwade, D. J., Hann, I., Webb, D. K. H., Wheatley, K., de Graaf, S. S. N., van den Berg, E., Burnett, A. K., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.8997 · Cited by 302
Self-citationLoken, M. R., Alonzo, T. A., Pardo, L., Gerbing, R. B., Raimondi, S. C., Hirsch, B. A., Ho, P. A., Franklin, J., Cooper, T. M., Gamis, A. S., et al. (2012) · Blood · doi:10.1182/blood-2012-02-408336 · Cited by 297
Pratcorona, M., Brunet, S., Nomdedéu, J., Ribera, J. M., Tormo, M., Duarte, R., Escoda, L., Guàrdia, R., Queipo de Llano, M. P., Salamero, O., et al. (2013) · Blood · doi:10.1182/blood-2012-06-431122 · Cited by 285
Gruber, T. A., Larson Gedman, A., Zhang, J., Koss, C. S., Marada, S., Ta, H. Q., Chen, S.-C., Su, X., Ogden, S. K., Dang, J., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.10.007 · Cited by 283
Self-citationThe MLL recombinome of acute leukemias
Meyer, C., Schneider, B., Jakob, S., Strehl, S., Attarbaschi, A., Schnittger, S., Schoch, C., Jansen, M. W. J. C., van Dongen, J. J. M., den Boer, M. L., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404150 · Cited by 271
Crenolanib is a potent inhibitor of FLT3 with activity against resistance-conferring point mutants
Galanis, A., Ma, H., Rajkhowa, T., Ramachandran, A., Small, D., Cortes, J., & Levis, M. (2014) · Blood · doi:10.1182/blood-2013-10-529313 · Cited by 252
Mathews, V., George, B., Chendamarai, E., Lakshmi, K. M., Desire, S., Balasubramanian, P., Viswabandya, A., Thirugnanam, R., Abraham, A., Shaji, R. V., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.5031 · Cited by 252
Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia
Goemans, B. F., Zwaan, C. M., Miller, M., Zimmermann, M., Harlow, A., Meshinchi, S., Loonen, A. H., Hählen, K., Reinhardt, D., Creutzig, U., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403870 · Cited by 243
Self-citationKaspers, G. J. L., Zimmermann, M., Reinhardt, D., Gibson, B. E. S., Tamminga, R. Y. J., Aleinikova, O., Armendariz, H., Dworzak, M. N., Ha, S., Hasle, H., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.7384 · Cited by 241
Self-citationDöhner, H., Lübbert, M., Fiedler, W., Fouillard, L., Haaland, A., Brandwein, J. M., Lepretre, S., Reman, O., Turlure, P., Ottmann, O. G., et al. (2014) · Blood · doi:10.1182/blood-2014-03-560557 · Cited by 231
Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia
Inaba, H., Coustan-Smith, E., Cao, X., Pounds, S. B., Shurtleff, S. A., Wang, K. Y., Raimondi, S. C., Onciu, M., Jacobsen, J., Ribeiro, R. C., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.5323 · Cited by 217
Self-citationThe incidence and clinical significance of nucleophosmin mutations in childhood AML
Brown, P., McIntyre, E., Rau, R., Meshinchi, S., Lacayo, N., Dahl, G., Alonzo, T. A., Chang, M., Arceci, R. J., & Small, D. (2007) · Blood · doi:10.1182/blood-2007-02-076604 · Cited by 216
Ho, P. A., Alonzo, T. A., Gerbing, R. B., Pollard, J., Stirewalt, D. L., Hurwitz, C., Heerema, N. A., Hirsch, B., Raimondi, S. C., Lange, B., et al. (2009) · Blood · doi:10.1182/blood-2008-10-184747 · Cited by 215
Creutzig, U., Reinhardt, D., Diekamp, S., Dworzak, M., Stary, J., & Zimmermann, M. (2005) · Leukemia · doi:10.1038/sj.leu.2403814 · Cited by 204
Self-citationPession, A., Masetti, R., Rizzari, C., Putti, M. C., Casale, F., Fagioli, F., Luciani, M., Lo Nigro, L., Menna, G., Micalizzi, C., et al. (2013) · Blood · doi:10.1182/blood-2013-03-491621 · Cited by 202
Self-citationCooper, T. M., Franklin, J., Gerbing, R. B., Alonzo, T. A., Hurwitz, C., Raimondi, S. C., Hirsch, B., Smith, F. O., Mathew, P., Arceci, R. J., et al. (2012) · Cancer · doi:10.1002/cncr.26190 · Cited by 199
Leung, W., Pui, C.-H., Coustan-Smith, E., Yang, J., Pei, D., Gan, K., Srinivasan, A., Hartford, C., Triplett, B. M., Dallas, M., et al. (2012) · Blood · doi:10.1182/blood-2012-02-409813 · Cited by 191
Self-citationSung, L., Nathan, P. C., Alibhai, S. M. H., Tomlinson, G. A., & Beyene, J. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-6-200709180-00010 · Cited by 190
Self-citationStability and prognostic influence of FLT3 mutations in paired initial and relapsed AML samples
Cloos, J., Goemans, B. F., Hess, C. J., van Oostveen, J. W., Waisfisz, Q., Corthals, S., de Lange, D., Boeckx, N., Hählen, K., Reinhardt, D., et al. (2006) · Leukemia · doi:10.1038/sj.leu.2404246 · Cited by 179
Self-citationLaszlo, G. S., Gudgeon, C. J., Harrington, K. H., Dell’Aringa, J., Newhall, K. J., Means, G. D., Sinclair, A. M., Kischel, R., Frankel, S. R., & Walter, R. B. (2014) · Blood · doi:10.1182/blood-2013-09-527044 · Cited by 173
Pediatric acute myeloid leukemia: international progress and future directions
Kaspers, G. J. L., & Creutzig, U. (2005) · Leukemia · doi:10.1038/sj.leu.2403958 · Cited by 172
Self-citationWalter, R. B., Othus, M., Burnett, A. K., Löwenberg, B., Kantarjian, H. M., Ossenkoppele, G. J., Hills, R. K., Ravandi, F., Pabst, T., Evans, A., et al. (2015) · Leukemia · doi:10.1038/leu.2014.242 · Cited by 170
Ravindranath, Y., Chang, M., Steuber, C. P., Becton, D., Dahl, G., Civin, C., Camitta, B., Carroll, A., Raimondi, S. C., Weinstein, H. J., et al. (2005) · Leukemia · doi:10.1038/sj.leu.2403927 · Cited by 167
Hollink, I. H. I. M., Zwaan, C. M., Zimmermann, M., Arentsen-Peters, T. C. J. M., Pieters, R., Cloos, J., Kaspers, G. J. L., de Graaf, S. S. N., Harbott, J., Creutzig, U., et al. (2009) · Leukemia · doi:10.1038/leu.2008.313 · Cited by 166
Self-citationde Rooij, J. D. E., Hollink, I. H. I. M., Arentsen-Peters, S. T. C. J. M., van Galen, J. F., Beverloo, H. B., Baruchel, A., Trka, J., Reinhardt, D., Sonneveld, E., Zimmermann, M., et al. (2013) · Leukemia · doi:10.1038/leu.2013.87 · Cited by 163
Self-citationArginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target
Mussai, F., Egan, S., Higginbotham-Jones, J., Perry, T., Beggs, A., Odintsova, E., Loke, J., Pratt, G., U, K. P., Lo, A., et al. (2015) · Blood · doi:10.1182/blood-2014-09-600643 · Cited by 163
Childhood and Adolescent Lymphoid and Myeloid Leukemia
Pui, C.-H., Schrappe, M., Ribeiro, R. C., & Niemeyer, C. M. (2004) · Hematology · doi:10.1182/asheducation-2004.1.118 · Cited by 163
Self-citationMasetti, R., Pigazzi, M., Togni, M., Astolfi, A., Indio, V., Manara, E., Casadio, R., Pession, A., Basso, G., & Locatelli, F. (2013) · Blood · doi:10.1182/blood-2012-11-469825 · Cited by 157
Self-citationRussell, J. A., & Storek, J. (2011) · Cited by 156
Hasle, H., Alonzo, T. A., Auvrignon, A., Béhar, C., Chang, M. N., Creutzig, U., Fischer, A., Forestier, E., Fynn, A. B., Haas, O. A., et al. (2007) · Blood · doi:10.1182/blood-2006-10-051342 · Cited by 154
Self-citationOstronoff, F., Othus, M. K. D., Gerbing, R. B., Loken, M. R., Raimondi, S. C., Hirsch, B. A., Lange, B. J., Petersdorf, S. H., Radich, J. P., Appelbaum, F. R., et al. (2014) · Blood · doi:10.1182/blood-2014-04-570929 · Cited by 146
Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia
Meshinchi, S., Stirewalt, D. L., Alonzo, T. A., Zhang, Q., Sweetser, D. A., Woods, W. G., Bernstein, I. D., Arceci, R. J., & Radich, J. P. (2003) · Blood · doi:10.1182/blood-2003-01-0137 · Cited by 146
van der Velden, V. H. J., van der Sluijs‐Gelling, A. J., Gibson, B. E. S., Marvelde, J. G. T., Hoogeveen, P. G., Hop, W. C. J., Wheatley, K., Bierings, M., Schuurhuis, G. J., de Graaf, S. S. N., et al. (2010) · Leukemia · doi:10.1038/leu.2010.153 · Cited by 143
Self-citationOmmen, H. B., Schnittger, S., Jovanovic, J. V., Ommen, I. B., Hasle, H., Østergaard, M., Grimwade, D. J., & Hokland, P. (2009) · Blood · doi:10.1182/blood-2009-04-212530 · Cited by 143
Self-citationMrózek, K., & Bloomfield, C. D. (2006) · Hematology · doi:10.1182/asheducation-2006.1.169 · Cited by 141
Sung, L., Robinson, P. D., Treister, N. S., Baggott, T., Gibson, P. J., Tissing, W. J. E., Wiernikowski, J. T., Brinklow, J., & Dupuis, L. L. (2015) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2014-000804 · Cited by 130
Self-citationJain, N., Curran, E. K., Iyengar, N. M., Díaz-Flores, E., Kunnavakkam, R., Popplewell, L. L., Kirschbaum, M. H., Karrison, T., Erba, H. P., Green, M., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-1311 · Cited by 129
Balgobind, B. V., Hollink, I. H. I. M., Arentsen-Peters, S. T. C. J. M., Zimmermann, M., Harbott, J., Beverloo, H. B., von Bergh, A. R. M., Cloos, J. J., Kaspers, G. J. L., de Haas, V., et al. (2011) · Haematologica · doi:10.3324/haematol.2010.038976 · Cited by 123
Self-citationImpact of FLT3ITD mutant allele level on relapse risk in intermediate-risk acute myeloid leukemia
Linch, D. C., Hills, R. K., Burnett, A. K., et al. (2014) · Blood · doi:10.1182/blood-2014-02-554667 · Cited by 122
Preclinical efficacy of MEK inhibition in Nras-mutant AML
Burgess, M. R., Hwang, E., Firestone, A. J., Huang, T. Q., Xu, J., Zuber, J. A., Bohin, N., Wen, T., Kogan, S. C., Haigis, K. M., et al. (2014) · Blood · doi:10.1182/blood-2014-05-574582 · Cited by 118
Coenen, E. A., Zwaan, C. M., Reinhardt, D., Harrison, C. J., Haas, O. A., de Haas, V., Mihál, V., Moerloose, B. D., Jeison, M., Rubnitz, J. E., et al. (2013) · Blood · doi:10.1182/blood-2013-02-485524 · Cited by 113
Self-citationSandahl, J. D., Coenen, E. A., Forestier, E., Harbott, J., Johansson, B., Kerndrup, G. B., Adachi, S., Auvrignon, A., Beverloo, H. B., Cayuela, J., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.098517 · Cited by 111
Self-citationGorman, M. F., Ji, L., Ko, R. H., Barnette, P., Bostrom, B., Hutchinson, R. J., Raetz, E. A., Seibel, N. L., Twist, C. J., Eckroth, E., et al. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22612 · Cited by 110
Kantarjian, H. M., Martinelli, G., Jabbour, E. J., Quintás‐Cardama, A., Ando, K., Bay, J., Wei, A. H., Gröpper, S., Papayannidis, C., Owen, K., et al. (2013) · Cancer · doi:10.1002/cncr.28113 · Cited by 105
Structural and numerical variation of FLT3/ITD in pediatric AML
Meshinchi, S., Stirewalt, D. L., Alonzo, T. A., Boggon, T. J., Gerbing, R. B., Rocnik, J. L., Lange, B. J., Gilliland, D. G., & Radich, J. P. (2008) · Blood · doi:10.1182/blood-2008-01-117770 · Cited by 104
Zwaan, C. M. (2003) · Blood · doi:10.1182/blood-2002-07-1947 · Cited by 101
Self-citationvon Bergh, A. R. M., van Drunen, E., van Wering, E. R., van Zutven, L. J. C. M., Hainmann, I., Lönnerholm, G., Meijerink, J. P. P., Pieters, R., & Beverloo, H. B. (2006) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20335 · Cited by 98
EVI1 overexpression in distinct subtypes of pediatric acute myeloid leukemia
Balgobind, B. V., Lugthart, S., Hollink, I. H. I. M., Arentsen-Peters, S. T. C. J. M., van Wering, E. R., de Graaf, S. S. N., Reinhardt, D., Creutzig, U., Kaspers, G. J. L., de Bont, E. S. J. M., et al. (2010) · Leukemia · doi:10.1038/leu.2010.47 · Cited by 97
Self-citationStumpel, D. J. P. M., Schneider, P., Seslija, L., Osaki, H., Williams, O., Pieters, R., & Stam, R. W. (2011) · Leukemia · doi:10.1038/leu.2011.278 · Cited by 95
Zwaan, C. M., Rizzari, C., Mechinaud, F. M., Lancaster, D. L., Lehrnbecher, T., van der Velden, V. H. J., Beverloo, B., den Boer, M. L., Pieters, R., Reinhardt, D., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.8280 · Cited by 95
Self-citationZwaan, C. M., Reinhardt, D., Zimmerman, M., Hasle, H., Starý, J., Stark, B., Dworzak, M. N., Creutzig, U., Kaspers, G. J. L., & on behalf of the International BFM Study Group on Paediatric AML (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.08011.x · Cited by 91
Self-citationHo, P. A., Zeng, R., Alonzo, T. A., Gerbing, R. B., Miller, K. L., Pollard, J. A., Stirewalt, D. L., Heerema, N. A., Raimondi, S. C., Hirsch, B. A., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268953 · Cited by 90
Abbott, B. L., Rubnitz, J. E., Tong, X., Srivastava, D. K., Pui, C.-H., Ribeiro, R. C., & Razzouk, B. I. (2003) · Leukemia · doi:10.1038/sj.leu.2403131 · Cited by 89
Self-citationHollink, I. H. I. M., van den Heuvel‐Eibrink, M. M., Arentsen-Peters, S. T. C. J. M., Zimmermann, M., Peeters, J. K., Valk, P. J. M., Balgobind, B. V., Sonneveld, E., Kaspers, G. J. L., de Bont, E. S. J. M., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.031336 · Cited by 75
Self-citationAntifungal prophylaxis in pediatric hematology/oncology: New choices & new data
Dvorak, C. C., Fisher, B. T., Sung, L., Steinbach, W. J., Nieder, M. L., Alexander, S. W., & Zaoutis, T. E. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23415 · Cited by 71
Self-citationStrategies to increase the ownership and use of insecticide-treated bednets to prevent malaria
Polec, L. A., Petkovic, J., Welch, V. A., Ueffing, E., Ghogomu, E. T., Pardo, J. P., Grabowsky, M., Attaran, A., Wells, G. A., & Tugwell, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009186.pub2 · Cited by 70
Mixed lineage rearranged leukaemia
Stein, E. M., & Tallman, M. S. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000123 · Cited by 69
van de Wetering, M. D., van Woensel, J. B. M., & Lawrie, T. A. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003295.pub3 · Cited by 66
Tomizawa, D., Tawa, A., Watanabe, T., Saito, A. M., Kudo, K., Taga, T., Iwamoto, S., Shimada, A., Terui, K., Moritake, H., et al. (2013) · Leukemia · doi:10.1038/leu.2013.153 · Cited by 65
Self-citationNovel therapies for children with acute myeloid leukaemia
Moore, A. S., Kearns, P. R., Knapper, S., Pearson, A. D. J., & Zwaan, C. M. (2013) · Leukemia · doi:10.1038/leu.2013.106 · Cited by 53
Self-citationHo, P. A., Alonzo, T. A., Gerbing, R. B., Pollard, J. A., Hirsch, B. A., Raimondi, S. C., Cooper, T. M., Gamis, A. S., & Meshinchi, S. (2013) · British Journal of Haematology · doi:10.1111/bjh.12444 · Cited by 46
Insights in dynamic kinome reprogramming as a consequence of MEK inhibition in MLL-rearranged AML
Kampen, K. R., ter Elst, A., Mahmud, H., Scherpen, F. J. G., Diks, S. H., Peppelenbosch, M. P., de Haas, V., Guryev, V., & de Bont, E. S. J. M. (2013) · Leukemia · doi:10.1038/leu.2013.342 · Cited by 45
Molecular Therapeutic Approaches for Pediatric Acute Myeloid Leukemia
Tasian, S. K., Pollard, J. A., & Aplenc, R. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00055 · Cited by 43
Self-citationWheatley, K., Goldstone, A. H., Littlewood, T. J., Hunter, A. E., & Burnett, A. K. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2009.07710.x · Cited by 39
Berman, J. N., Gerbing, R. B., Alonzo, T. A., Ho, P. A., Miller, K. L., Hurwitz, C. A., Heerema, N. A., Hirsch, B. A., Raimondi, S. C., Lange, B. J., et al. (2011) · Leukemia · doi:10.1038/leu.2011.31 · Cited by 35
Matsuo, H., Kajihara, M., Tomizawa, D., Watanabe, T., Saito, A. M., Fujimoto, J., Horibe, K., Kodama, K., Tokumasu, M., Itoh, H., et al. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.47 · Cited by 32
Self-citationLancet, J. E., Roboz, G. J., Cripe, L. D., Michelson, G. C., Fox, J. A., Leavitt, R. D., Chen, T., Hawtin, R., Craig, A. R., Ravandi, F., et al. (2014) · Haematologica · doi:10.3324/haematol.2014.114769 · Cited by 29
Approaches to Induction Therapy with Adult Acute Myeloid Leukaemia
Bishop, J. F. (1998) · Acta Haematologica · doi:10.1159/000040827 · Cited by 16
Lange, B. J., Yang, R. K., Gan, J., Hank, J. A., Sievers, E. L., Alonzo, T. A., Gerbing, R. B., & Sondel, P. M. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22966 · Cited by 14
Cited by
MLL-Rearranged Leukemias—An Update on Science and Clinical Approaches
Winters, A. C., & Bernt, K. M. (2017) · Frontiers in Pediatrics · doi:10.3389/fped.2017.00004 · Cited by 405
Venetoclax for paediatric acute myeloid leukaemia: a step forward
Aplenc, R. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30136-4 · Cited by 1
Self-citation
Metadata
- Authors
- Zwaan, C. M., Kolb, E. A., Reinhardt, D., Abrahamsson, J., Adachi, S., Aplenc, R., De Bont, E. S. J. M., De Moerloose, B., Dworzak, M., Gibson, B. E. S., Hasle, H., Leverger, G., Locatelli, F., Ragu, C., Ribeiro, R. C., Rizzari, C., Rubnitz, J. E., Smith, O. P., Sung, L., Tomizawa, D., van den Heuvel-Eibrink, M. M., Creutzig, U., & Kaspers, G. J. L.
- Venue
- Journal of Clinical Oncology
- Published
- 2015-09-20
- Volume
- 33
- Issue
- 27
- Pages
- 2949-2962
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2132693111
- Cited by
- 383
- References
- 98
- FWCI
- 19.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.